The PIK3CA wild-type cohort of the Phase 3 VIKTORIA-1 trial is 100% enrolled; expect to report topline data for this cohort in late Q1 2025 or Q2 2025Approximately $264 million in cash, cash ...
Vivos Therapeutics, Inc. ( NASDAQ: VVOS) Q3 2024 Earnings Conference Call November 14, 2024 5:00 PM ET Kirk Huntsman - Chariman & CEO Brad Amman - CFO Scott Henry - Alliance Global Partners Lucas Ward ...
As of September 30, 2024, Base Carbon has funded 43% of the committed project capital with all further capital commitment funding tied to achievement of specific project milestones. Project validation ...
Sow Good Inc. ( NASDAQ: SOWG) Q3 2024 Earnings Conference Call November 14, 2024 10:00 AM ET Cody Slach - Investor Relations Claudia Goldfarb - Co-Founder and CEO Brendon Fischer - Interim Chief ...
The acquisition of Tata Communications Payment Solutions will significantly expand Findi's ATM business, adding 4,600 ATMs and a White Label ATM platform with licence, the Australia-based firm said in ...